| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Oct 13, 2023 |
|||||||||
| Q3 FY23 | $6.56 | $6.32 | $91.36B | $86.59B |
NYSE |
||||
| Q3 FY23 | $4.33 | $3.89 | $39.76B | $39.56B |
NYSE |
||||
| Q3 FY23 | $1.39 | $1.24 | $20.86B | $20.12B |
NYSE |
||||
| Q3 FY23 | $1.52 | $1.21 | $19.74B | $19.32B |
NYSE |
||||
| - | $2.09 | $1.71 | $15.59B | $15.40B |
NYSE |
||||
|
The PNC Financial Services Group
PNC
|
Q3 FY23 | $3.60 | $3.11 | $5.23B | $5.37B |
NYSE |
|||
| Q3 FY23 | $10.91 | $8.26 | $4.52B | $4.51B |
NYSE |
||||
|
Hingham Institution for Savings
HIFS
|
- | $1.32 | - | $45.84M | - |
NASDAQ |
|||
FingerMotion
FNGR
|
- | - | - | $9.28M | $14.80M |
NASDAQ |
|||
|
Pro-Dex
PDEX
|
- | $0.42 | $0.32 | $11.94M | $11.50M |
NASDAQ |
|||
|
Aileron Therapeutics
ALRN
|
- | -$0.40 | -$0.20 | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
